← Evidence map

ReviewJournal of food and drug analysis2019

The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond.

Lin-Chau ChangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31324283